Jihong Han Selected Research

Carthamus tinctorius Honghua extract

1/2020	Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications.
5/2014	Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jihong Han Research Topics

Disease

37	Atherosclerosis 08/2023 - 01/2008
23	Inflammation (Inflammations) 04/2023 - 04/2014
16	Neoplasms (Cancer) 04/2024 - 07/2010
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 06/2002
8	Fatty Liver 01/2022 - 01/2018
7	Coronary Disease (Coronary Heart Disease) 08/2023 - 11/2004
6	Breast Neoplasms (Breast Cancer) 04/2024 - 05/2015
6	Insulin Resistance 03/2024 - 01/2019
6	Heart Failure 03/2023 - 01/2016
5	Carcinoma (Carcinomatosis) 12/2023 - 04/2014
5	Fibrosis (Cirrhosis) 03/2023 - 11/2019
5	Vascular Calcification 01/2022 - 10/2018
4	Hypercholesterolemia 03/2023 - 01/2017
4	Hypertriglyceridemia 01/2023 - 04/2015
4	Thrombosis (Thrombus) 01/2022 - 09/2003
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 01/2018
3	Obesity 04/2023 - 01/2020
3	Necrosis 01/2023 - 11/2019
3	Cholestasis 01/2023 - 01/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 11/2019
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2018
3	Sepsis (Septicemia) 12/2021 - 01/2018
3	Non-alcoholic Fatty Liver Disease 12/2020 - 02/2018
3	Vascular Diseases (Vascular Disease) 03/2020 - 01/2019
3	Dyslipidemias (Dyslipidemia) 01/2020 - 04/2015
2	Liver Neoplasms (Liver Cancer) 10/2023 - 01/2023
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 12/2018
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 01/2022
2	Heart Diseases (Heart Disease) 09/2022 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 11/2021
2	Ischemic Stroke 01/2022 - 01/2019
2	Stroke (Strokes) 01/2022 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 11/2021 - 12/2018
2	Wounds and Injuries (Trauma) 06/2021 - 01/2017
2	Cardiotoxicity 06/2021 - 12/2020
2	Atrophy 03/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

18	LipidsIBA 03/2024 - 09/2003
18	Apolipoproteins E (ApoE)IBA 03/2023 - 04/2015
11	LigandsIBA 04/2024 - 06/2009
11	CholesterolIBA 01/2023 - 06/2002
9	Capsules (Microcapsules)IBA 01/2021 - 01/2015
9	Liver X ReceptorsIBA 01/2021 - 12/2012
8	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 06/2015
7	T0901317IBA 01/2021 - 04/2014
7	naoxintongIBA 01/2021 - 01/2015
6	ApolipoproteinsIBA 03/2023 - 05/2014
5	Proteins (Proteins, Gene)FDA Link 08/2023 - 12/2007
5	LDL Receptors (LDL Receptor)IBA 03/2023 - 01/2008
5	Rosiglitazone (Avandia)FDA Link 01/2023 - 11/2019
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 03/2020
5	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 03/2020
5	U 0126 (UO 126)IBA 01/2022 - 02/2015
5	CollagenIBA 03/2021 - 05/2015
5	danhongIBA 01/2018 - 05/2014
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2021
4	pitavastatin (itavastatin)FDA Link 01/2024 - 09/2003
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2023 - 01/2016
4	Transcription Factors (Transcription Factor)IBA 06/2021 - 12/2012
4	LongShengZhiIBA 03/2020 - 01/2019
4	oxidized low density lipoproteinIBA 01/2020 - 12/2012
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018 - 11/2004
3	EnzymesIBA 04/2024 - 03/2020
3	IsoflavonesIBA 04/2023 - 01/2020
3	AdiponectinIBA 01/2023 - 01/2017
3	AntioxidantsIBA 09/2022 - 09/2015
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2016
3	CarrageenanIBA 01/2022 - 01/2018
3	Monoamine Oxidase (MAO)IBA 11/2021 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 11/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021 - 11/2019
3	Collagen Type I (Type I Collagen)IBA 03/2021 - 11/2019
3	InterferonsIBA 01/2021 - 02/2015
3	CytokinesIBA 01/2021 - 11/2011
3	Tamoxifen FDA LinkGeneric 12/2018 - 05/2015
3	trioctyl phosphine oxide (TOPO)IBA 12/2018 - 06/2013
3	Teniposide (VM 26)FDA Link 12/2018 - 06/2013
3	buchang naoxintongIBA 01/2017 - 01/2015
3	Fatty Acid-Binding ProteinsIBA 08/2015 - 06/2012
2	Carrier Proteins (Binding Protein)IBA 03/2024 - 01/2022
2	CarbohydratesIBA 03/2024 - 12/2020
2	Streptozocin (Streptozotocin)FDA Link 12/2023 - 01/2021
2	fibroblast growth factor 21IBA 12/2023 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2020
2	Ethanol (Ethyl Alcohol)IBA 04/2023 - 01/2020
2	danshen dripping pillIBA 03/2023 - 06/2021
2	NF-kappa B (NF-kB)IBA 01/2023 - 12/2022
2	AMP-Activated Protein KinasesIBA 01/2023 - 01/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 03/2021
2	Adenosine Triphosphate (ATP)IBA 09/2022 - 12/2019
2	Sirtuin 3IBA 09/2022 - 03/2020
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Toll-Like Receptor 4IBA 03/2021 - 01/2021
2	CatalaseIBA 03/2021 - 03/2020
2	Glutathione PeroxidaseIBA 03/2021 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2020
2	PPAR gammaIBA 01/2021 - 06/2009

Therapy/Procedure

10	Therapeutics 03/2023 - 07/2010
8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2019
2	Oral Administration 01/2021 - 01/2021